These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15813874)

  • 21. Universal newborn hearing screening: a 27-month experience in the French region of Champagne-Ardenne.
    Lévêque M; Schmidt P; Leroux B; Danvin JB; Langagne T; Labrousse M; Chays A
    Acta Paediatr; 2007 Aug; 96(8):1150-4. PubMed ID: 17578491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in age of identification and intervention in infants with hearing loss.
    Harrison M; Roush J; Wallace J
    Ear Hear; 2003 Feb; 24(1):89-95. PubMed ID: 12598815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Universal hearing screening in the Champagne-Ardenne regions: results and consideration after 55 000 births from January 2004 to June 2007].
    Langagne T; Schmidt P; Leveque M; Chays A
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(3):153-8. PubMed ID: 19694157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-based universal newborn hearing screening for early detection of permanent congenital hearing loss in Lagos, Nigeria.
    Olusanya BO; Wirz SL; Luxon LM
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):991-1001. PubMed ID: 18433883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligurian experience on neonatal hearing screening: clinical and epidemiological aspects.
    Calevo MG; Mezzano P; Zullino E; Padovani P; Serra G;
    Acta Paediatr; 2007 Nov; 96(11):1592-9. PubMed ID: 17937684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alternative strategy for universal infant hearing screening in tertiary hospitals with a high delivery rate, within a developing country, using transient evoked oto-acoustic emissions and brainstem evoked response audiometry.
    Mathur NN; Dhawan R
    J Laryngol Otol; 2007 Jul; 121(7):639-43. PubMed ID: 17112395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organisation of a universal newborn hearing screening programme in Flanders.
    Van Kerschaver E; Boudewyns AN; Stappaerts L; Wuyts FL; Van de Heyning PH
    B-ENT; 2007; 3(4):185-90. PubMed ID: 18265723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening methods: current status.
    Hayes D
    Ment Retard Dev Disabil Res Rev; 2003; 9(2):65-72. PubMed ID: 12784223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn hearing screening by transient evoked otoacoustic emissions: analysis of response as a function of risk factors.
    De Capua B; De Felice C; Costantini D; Bagnoli F; Passali D
    Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):16-20. PubMed ID: 12812130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MB11 BERAphone and auditory brainstem response in newborns at audiologic risk: comparison of results.
    Melagrana A; Casale S; Calevo MG; Tarantino V
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1175-80. PubMed ID: 17532479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polish universal neonatal hearing screening program-4-year experience (2003-2006).
    Szyfter W; Wróbel M; Radziszewska-Konopka M; Szyfter-Harris J; Karlik M
    Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1783-7. PubMed ID: 18922586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying congenital hearing impairment. Personal experience based on selective hearing screening.
    Molini E; Ricci G; Baroni S; Ciorba A; Bellocci A; Simoncelli C
    Acta Otorhinolaryngol Ital; 2004 Jun; 24(3):109-16. PubMed ID: 15584580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory steady-state responses to bone conduction stimuli in children with hearing loss.
    Swanepoel de W; Ebrahim S; Friedland P; Swanepoel A; Pottas L
    Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1861-71. PubMed ID: 18963045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn hearing screening devices: sound advice on choosing the right technology.
    Health Devices; 2005 Oct; 34(10):350-6. PubMed ID: 16355928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of hearing screening with developmental outcomes in infants over a 2-year period.
    Chiong C; Ostrea E; Reyes A; Llanes EG; Uy ME; Chan A
    Acta Otolaryngol; 2007 Apr; 127(4):384-8. PubMed ID: 17453458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and performance of early hearing detection programmes in Lagos, Nigeria.
    Olusanya BO; Emokpae A; Renner JK; Wirz SL
    Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):179-86. PubMed ID: 18814895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of long-lasting parental concern after false-positive results of neonatal hearing screening.
    van der Ploeg CP; Lanting CI; Kauffman-de Boer MA; Uilenburg NN; de Ridder-Sluiter JG; Verkerk PH
    Arch Dis Child; 2008 Jun; 93(6):508-11. PubMed ID: 18218661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hearing screening of neonates at risk.
    Maisoun AM; Zakzouk SM
    Saudi Med J; 2003 Jan; 24(1):55-7. PubMed ID: 12590276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of neonatal screening for hearing loss by otoacoustic emission.
    Watkin PM
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F158-68. PubMed ID: 8976680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six month impact of false positives in an Australian infant hearing screening programme.
    Poulakis Z; Barker M; Wake M
    Arch Dis Child; 2003 Jan; 88(1):20-4. PubMed ID: 12495952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.